DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Cardiology Homepage

Fewer ICDs are failing to comply with CMS NCD standards, says study Follows DOJ investigation into overuse of non-NCD-compliant ICDs

DaVita hit with $383.5 million jury verdict in dialysis death suit Three patients suffered cardiac arrest after getting GranuFlo therapy

New research finds leadless pacemakers cause fewer complications than conventional option Will they become the new standard?

Cardioverter defibrillator vest may be viable alternative to pediatric implants Promising study results may help patients unfit for surgery

Ivor Benjamin American Heart Association seats new president and officers as chairman enters 2nd of two-year term

Siemens announces first global installation of Biograph Vision PET/CT System yields better temporal resolution and sensitivity than previously reported

GE launched Syntermed's Emory Cardiac Toolbox at SNMMI Affordable option for users with older SPECT systems

William Kozy LivaNova welcomes new board of directors member

Philips to acquire EPD Solutions for approx. $295 million Company has its eye on the EUR 2+ billion cardiac arrhythmia ablation market

FDA greenlights Neural Analytics' NeuralBot System Assesses risk of stroke and other neurological conditions

80 million Americans
now have access

Three health plans announce coverage for HeartFlow FFRct Analysis

by Lauren Dubinsky , Senior Reporter
Three health plans recently decided to provide coverage for the HeartFlow FFRct Analysis technology.

Anthem Blue Cross Blue Shield, Blue Shield of California, and Blue Cross and Blue Shield of Alabama provide health insurance for 44 million patients. After evaluating the technology’s technical performance, diagnostic accuracy, clinical utility and clinical benefits, they determined it’s medically necessary for members with stable chest pain after a coronary CT angiogram is performed.

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

Coronary artery disease accounts for about one in every five deaths in developed countries, making it the most common cause of mortality in those regions, according to a study published in Mayo Clinic Proceedings. The HeartFlow Analysis evaluates the extent of CAD as well as the impact it has on blood flow to the heart.

Dr. John H. Stevens, president and CEO of HeartFlow, stated that an increasing number of national and regional commercial payors are providing coverage for the technology. That’s largely due to the evidence that it reduces the need for noninvasive and invasive tests and procedures, and lowers health care costs.

“With the growing number of health plans covering our technology, even more patients with suspected CAD will benefit by receiving a definitive personalized treatment plan based on the HeartFlow Analysis,” he said in a statement.

The other commercial payors include Aetna, which covers over 23 million lives, and additional Blue Cross Blue Shield companies that collectively have almost 5.5 million members. Nearly 80 million Americans now have access to HeartFlow Analysis.

The company that conducts health care technology evaluations for the Blue Cross Blue Shield Association is called Evidence Street. In June, it issued a review that determined HeartFlow Analysis provides a “meaningful improvement in net health outcome” in patients with stable chest pain.

The National Institute for Health and Care Excellence of the U.K.’s National Health Service, which covers 59 million lives, also issued guidance that recommended HeartFlow Analysis for determining the cause of stable chest pain.

The American College of Cardiology and the American Heart Association recently released Appropriate Use Criteria for patients with stable ischemic heart disease undergoing coronary revascularization. It included the use of HeartFlow Analysis for gauging the appropriateness of revascularization in many clinical scenarios.

In other news, Philips and HeartFlow Inc. announced a partnership on Monday to promote the combined use of HeartFlow Analysis and Philips’ advanced catheters. The companies have also entered a collaboration agreement to develop a cath lab X-ray image-derived fraction flow reserve or instant wave-free ratio solution.

Cardiology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.